Pronociceptive actions of dynorphin maintain chronic neuropathic pain

Zaijie Wang, Luis R. Gardell, Michael H. Ossipov, Todd W Vanderah, Miles B. Brennan, Ute Hochgeschwender, Victor J Hruby, T. Phil Malan, Josephine Lai, Frank Porreca

Research output: Contribution to journalArticle

220 Citations (Scopus)

Abstract

Whereas tissue injury increases spinal dynorphin expression, the functional relevance of this upregulation to persistent pain is unknown. Here, mice lacking the prodynorphin gene were studied for sensitivity to non-noxious and noxious stimuli, before and after induction of experimental neuropathic pain. Prodynorphin knock-out (KO) mice had normal responses to acute non-noxious stimuli and a mild increased sensitivity to some noxious stimuli. After spinal nerve ligation (SNL), both wild-type (WT) and KO mice demonstrated decreased thresholds to innocuous mechanical and to noxious thermal stimuli, indicating that dynorphin is not required for initiation of neuropathic pain. However, whereas neuropathic pain was sustained in WT mice, KO mice showed a return to baselines by post-SNL day 10. In WT mice, SNL upregulated lumbar dynorphin content on day 10, but not day 2, after injury. Intrathecal dynorphin antiserum reversed neuropathic pain in WT mice at post-SNL day 10 (when dynorphin was upregulated) but not on post-SNL day 2; intrathecal MK-801 reversed SNL-pain at both times. Opioid (μ, δ, and κ) receptor density and G-protein activation were not different between WT and KO mice and were unchanged by SNL injury. The observations suggest (1) an early, dynorphin-independent phase of neuropathic pain and a later dynorphin-dependent stage, (2) that upregulated spinal dynorphin is pronociceptive and required for the maintenance of persistent neuropathic pain, and (3) that processes required for the initiation and the maintenance of the neuropathic pain state are distinct. Identification of mechanisms that maintain neuropathic pain appears important for strategies to treat neuropathic pain.

Original languageEnglish (US)
Pages (from-to)1779-1786
Number of pages8
JournalJournal of Neuroscience
Volume21
Issue number5
StatePublished - Mar 1 2001

Fingerprint

Dynorphins
Neuralgia
Chronic Pain
Spinal Nerves
Ligation
Knockout Mice
Maintenance
Spinal Injuries
Dizocilpine Maleate
Wounds and Injuries
Opioid Receptors
GTP-Binding Proteins
Immune Sera
Up-Regulation
Hot Temperature

Keywords

  • Dynorphin
  • Gene deletion
  • Gene knockout
  • Mouse
  • Neuropathic pain
  • Nociception
  • Opioid receptors
  • Prodynorphin
  • Spinal nerve injury
  • Transgenic

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Wang, Z., Gardell, L. R., Ossipov, M. H., Vanderah, T. W., Brennan, M. B., Hochgeschwender, U., ... Porreca, F. (2001). Pronociceptive actions of dynorphin maintain chronic neuropathic pain. Journal of Neuroscience, 21(5), 1779-1786.

Pronociceptive actions of dynorphin maintain chronic neuropathic pain. / Wang, Zaijie; Gardell, Luis R.; Ossipov, Michael H.; Vanderah, Todd W; Brennan, Miles B.; Hochgeschwender, Ute; Hruby, Victor J; Phil Malan, T.; Lai, Josephine; Porreca, Frank.

In: Journal of Neuroscience, Vol. 21, No. 5, 01.03.2001, p. 1779-1786.

Research output: Contribution to journalArticle

Wang, Z, Gardell, LR, Ossipov, MH, Vanderah, TW, Brennan, MB, Hochgeschwender, U, Hruby, VJ, Phil Malan, T, Lai, J & Porreca, F 2001, 'Pronociceptive actions of dynorphin maintain chronic neuropathic pain', Journal of Neuroscience, vol. 21, no. 5, pp. 1779-1786.
Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, Hochgeschwender U et al. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. Journal of Neuroscience. 2001 Mar 1;21(5):1779-1786.
Wang, Zaijie ; Gardell, Luis R. ; Ossipov, Michael H. ; Vanderah, Todd W ; Brennan, Miles B. ; Hochgeschwender, Ute ; Hruby, Victor J ; Phil Malan, T. ; Lai, Josephine ; Porreca, Frank. / Pronociceptive actions of dynorphin maintain chronic neuropathic pain. In: Journal of Neuroscience. 2001 ; Vol. 21, No. 5. pp. 1779-1786.
@article{24b33d7607e44aeda04bb2ace6a21d99,
title = "Pronociceptive actions of dynorphin maintain chronic neuropathic pain",
abstract = "Whereas tissue injury increases spinal dynorphin expression, the functional relevance of this upregulation to persistent pain is unknown. Here, mice lacking the prodynorphin gene were studied for sensitivity to non-noxious and noxious stimuli, before and after induction of experimental neuropathic pain. Prodynorphin knock-out (KO) mice had normal responses to acute non-noxious stimuli and a mild increased sensitivity to some noxious stimuli. After spinal nerve ligation (SNL), both wild-type (WT) and KO mice demonstrated decreased thresholds to innocuous mechanical and to noxious thermal stimuli, indicating that dynorphin is not required for initiation of neuropathic pain. However, whereas neuropathic pain was sustained in WT mice, KO mice showed a return to baselines by post-SNL day 10. In WT mice, SNL upregulated lumbar dynorphin content on day 10, but not day 2, after injury. Intrathecal dynorphin antiserum reversed neuropathic pain in WT mice at post-SNL day 10 (when dynorphin was upregulated) but not on post-SNL day 2; intrathecal MK-801 reversed SNL-pain at both times. Opioid (μ, δ, and κ) receptor density and G-protein activation were not different between WT and KO mice and were unchanged by SNL injury. The observations suggest (1) an early, dynorphin-independent phase of neuropathic pain and a later dynorphin-dependent stage, (2) that upregulated spinal dynorphin is pronociceptive and required for the maintenance of persistent neuropathic pain, and (3) that processes required for the initiation and the maintenance of the neuropathic pain state are distinct. Identification of mechanisms that maintain neuropathic pain appears important for strategies to treat neuropathic pain.",
keywords = "Dynorphin, Gene deletion, Gene knockout, Mouse, Neuropathic pain, Nociception, Opioid receptors, Prodynorphin, Spinal nerve injury, Transgenic",
author = "Zaijie Wang and Gardell, {Luis R.} and Ossipov, {Michael H.} and Vanderah, {Todd W} and Brennan, {Miles B.} and Ute Hochgeschwender and Hruby, {Victor J} and {Phil Malan}, T. and Josephine Lai and Frank Porreca",
year = "2001",
month = "3",
day = "1",
language = "English (US)",
volume = "21",
pages = "1779--1786",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "5",

}

TY - JOUR

T1 - Pronociceptive actions of dynorphin maintain chronic neuropathic pain

AU - Wang, Zaijie

AU - Gardell, Luis R.

AU - Ossipov, Michael H.

AU - Vanderah, Todd W

AU - Brennan, Miles B.

AU - Hochgeschwender, Ute

AU - Hruby, Victor J

AU - Phil Malan, T.

AU - Lai, Josephine

AU - Porreca, Frank

PY - 2001/3/1

Y1 - 2001/3/1

N2 - Whereas tissue injury increases spinal dynorphin expression, the functional relevance of this upregulation to persistent pain is unknown. Here, mice lacking the prodynorphin gene were studied for sensitivity to non-noxious and noxious stimuli, before and after induction of experimental neuropathic pain. Prodynorphin knock-out (KO) mice had normal responses to acute non-noxious stimuli and a mild increased sensitivity to some noxious stimuli. After spinal nerve ligation (SNL), both wild-type (WT) and KO mice demonstrated decreased thresholds to innocuous mechanical and to noxious thermal stimuli, indicating that dynorphin is not required for initiation of neuropathic pain. However, whereas neuropathic pain was sustained in WT mice, KO mice showed a return to baselines by post-SNL day 10. In WT mice, SNL upregulated lumbar dynorphin content on day 10, but not day 2, after injury. Intrathecal dynorphin antiserum reversed neuropathic pain in WT mice at post-SNL day 10 (when dynorphin was upregulated) but not on post-SNL day 2; intrathecal MK-801 reversed SNL-pain at both times. Opioid (μ, δ, and κ) receptor density and G-protein activation were not different between WT and KO mice and were unchanged by SNL injury. The observations suggest (1) an early, dynorphin-independent phase of neuropathic pain and a later dynorphin-dependent stage, (2) that upregulated spinal dynorphin is pronociceptive and required for the maintenance of persistent neuropathic pain, and (3) that processes required for the initiation and the maintenance of the neuropathic pain state are distinct. Identification of mechanisms that maintain neuropathic pain appears important for strategies to treat neuropathic pain.

AB - Whereas tissue injury increases spinal dynorphin expression, the functional relevance of this upregulation to persistent pain is unknown. Here, mice lacking the prodynorphin gene were studied for sensitivity to non-noxious and noxious stimuli, before and after induction of experimental neuropathic pain. Prodynorphin knock-out (KO) mice had normal responses to acute non-noxious stimuli and a mild increased sensitivity to some noxious stimuli. After spinal nerve ligation (SNL), both wild-type (WT) and KO mice demonstrated decreased thresholds to innocuous mechanical and to noxious thermal stimuli, indicating that dynorphin is not required for initiation of neuropathic pain. However, whereas neuropathic pain was sustained in WT mice, KO mice showed a return to baselines by post-SNL day 10. In WT mice, SNL upregulated lumbar dynorphin content on day 10, but not day 2, after injury. Intrathecal dynorphin antiserum reversed neuropathic pain in WT mice at post-SNL day 10 (when dynorphin was upregulated) but not on post-SNL day 2; intrathecal MK-801 reversed SNL-pain at both times. Opioid (μ, δ, and κ) receptor density and G-protein activation were not different between WT and KO mice and were unchanged by SNL injury. The observations suggest (1) an early, dynorphin-independent phase of neuropathic pain and a later dynorphin-dependent stage, (2) that upregulated spinal dynorphin is pronociceptive and required for the maintenance of persistent neuropathic pain, and (3) that processes required for the initiation and the maintenance of the neuropathic pain state are distinct. Identification of mechanisms that maintain neuropathic pain appears important for strategies to treat neuropathic pain.

KW - Dynorphin

KW - Gene deletion

KW - Gene knockout

KW - Mouse

KW - Neuropathic pain

KW - Nociception

KW - Opioid receptors

KW - Prodynorphin

KW - Spinal nerve injury

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=0035282798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035282798&partnerID=8YFLogxK

M3 - Article

C2 - 11222667

AN - SCOPUS:0035282798

VL - 21

SP - 1779

EP - 1786

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 5

ER -